NFE2L2 and esophageal squamous cell carcinoma: Lu et al. [61] demonstrated by targeting Nrf2 in ESCC that sulforaphane (SFN), a natural anticancer compound, induced apoptosis and inhibited autophagy, thereby improving anticancer efficiency in ESCC patients.